BMI Impacts SLN Mapping in Gynecologic Cancer
Prior research has examined sentinel lymph node (SLN) mapping among patients with a range of BMI...
Read More
Meeting Coverage
AAN 2022 Virtual
Can’t make it to AAN in person? Don’t worry because the conference is continuing to host virtually as well. This year, the virtual conference will take place April 24-26, with access to session recordings through May...
Read MoreAAN Schedule Highlights
April 2, 7:00 PM – 10:00 PM Industry Therapeutic Update from EMD Serono, Inc.: Early DMT switch considerations in MS and discussing the capacity to mount an immune response April 3, 5:00 PM – 5:30 PM AAN Leadership...
Read MoreAAN Covid-19 Safety Protocals
Proof of Vaccination + Mask Requirement All in-person attendees, exhibitors, press personnel, guests, and staff must complete the COVID-19 vaccination process with an acceptable vaccine and booster, if eligible, a minimum of 7...
Read More
Ozanimod Safe & Effective in DAYBREAK Open-Label Extension
For patients with multiple sclerosis (MS), ozanimod provides continued control of disease activity...
Read MoreStructural Brain Damage & Cognitive Impairment Association
In individuals with multiple sclerosis (MS), researchers sought to determine the role of cognitive dysfunction in motor disability and structural disease-related burden. About 81 healthy controls and 109 relapsing-remitting (RR)...
Read MoreRelapsing Multiple Sclerosis and its Links
In the OPTIMUM trial, researchers sought to determine disability, cognition, motor function, and multiple sclerosis (MS) fatigue in relation to baseline and change in brain volume (BV). Over the course of 108 weeks, patients...
Read MorePrognosis communication for Multiple Sclerosis Patients
For a study, the researchers sought to look at early-stage relapsing-remitting multiple sclerosis (RRMS) patients’ long-term prognosis (LTP) communication preferences and factors. A non-interventional, multicenter trial...
Read MoreKetogenic Diet as a Strategy in Relapsing Multiple Sclerosis
For a study, the researchers sought to determine the safety and tolerability of a ketogenic diet (KD) in relapsing MS patients and the influence on patient-reported, laboratory, and clinical outcome measures. Investigators...
Read MoreEfficacy of Cognitive-Behavioral Methods in RRMS Patients
For a study, the researchers sought to compare the efficacy and tolerability of a 6-week cognitive-behavioral approaches (CBT) program with booster sessions for a year to conventional therapy on the severity and impact of...
Read MoreDisease Activity in Patients With Relapsing Multiple Sclerosis
No evidence of disease activity 3 and 4 (NEDA-3 and NEDA-4) in RMS patients treated with ozanimod were evaluated. Data were gathered from a randomized phase 3 trial (RADIANCE, NCT02047734) comparing oral ozanimod 0.92 mg/d to...
Read MorePhase 3 and Extension Trials With Ozanimod Therapy on Cortical Grey Matter Volume
The researchers evaluated the size and duration of interferon-induced changes in cortical grey matter volume (CGMV) for a study. In addition, they examined the long-term effects of switching to ozanimod in relapsing multiple...
Read MoreResponse to SARS-CoV-2 Vaccine in RMS Patients Using Ozanimod
For a study, the researchers sought to characterize antibody and T-cell responses to the 3 SARS-CoV-2 vaccinations now available in the United States (US) in patients with relapsed multiple sclerosis (RMS) who were using...
Read MoreFibulin-2, An Extracellular Matrix Remyelination Inhibitor
For a study, the researchers sought to assess FBLN2 expression in MS and EAE lesions to see if the ECM molecule could alter oligodendrocyte maturation and remyelination. The study team discovered elevated levels of FBLN2 in EAE...
Read MoreSex, Hormones, and Age Interactions in MS Prognosis
The researchers sought to examine aging-related mechanisms in MS prognosis for a study. They also sought to determine sex-specific elements that influence MS prognosis and explore the link between sex, hormones, and aging in MS...
Read MoreUse of Electronic Health Records as Prognostic Indicator
For a study, the researchers sought to undertake 2 analyses. They combined EHR data with gold-standard data from a well-established clinic-based research registry. First, they used a 2-stage process to develop models that...
Read MoreCognitive Function Improvement in the Patients With MS
For a study, the researchers sought to compare the cognitive effects of active vs sham tDCS combined with adaptive cognitive training (aCT) administered as an at-home intervention in adults with MS in a randomized...
Read MoreSerum Neurofilament For Gray Matter Atrophy And Clinical Impairment in MS
For a study, the researchers examined the relationship between sNfL levels throughout a 2-year period and clinical disability and gray matter (GM) atrophy after 10 years in early relapsing-remitting MS (RRMS) patients. A total...
Read MoreBenefits of Disease-Modifying Therapy in MS Patients
For a study, the researchers sought to forecast the conditional average treatment effect (CATE) for people on anti-CD20 monoclonal antibodies and laquinimod for a study. For this, researchers used a multitask multilayer...
Read More